1 |
Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes. (IF:5.555) |
Rajarajan S, Korlimarla A, Alexander A, Anupama CE, Ramesh R, Srinath BS, Sridhar TS, Prabhu JS. |
Frontiers in endocrinology. |
2021 |
2 |
miRNAs: Critical mediators of breast cancer metastatic programming. (IF: 3.905) |
Nair MG, Somashekaraiah VM, Ramamurthy V, Prabhu JS, Sridhar TS. |
Experimental Cell Research. |
2021 |
3 |
Gender disparity in COVID-19: Role of sex steroid hormones. (IF:2.285) |
Lipsa A, Prabhu JS. |
Asian Pacific journal of tropical medicine. |
2021 |
4 |
High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis. (Cite score- 1.2) |
Nair MG, Prabhu JS, Sridhar TS. |
Cancer treatment and research communications. |
2021 |
5 |
Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity. (IF:2.762) |
Crasta J, Ravikumar G, Rajarajan S, Gali S, Kulkarni KA, Vallikad E, Prabhu J. |
International Journal of Gynecological Pathology |
2021 |
6 |
Living with cancer: Urgent need for emotional health support |
Alexander A, Murthy RS |
Indian J Cancer |
2020 |
7 |
Beyond numbers – Recent understanding of emotional needs of persons diagnosed with cancer 2007–2018 |
Alexander A, Sreenath K, Murthy RS |
Indian J Palliat Care |
2020 |
8 |
miR-18a Activates Wnt Pathway in ER-positive Breast Cancer and Is Associated With Poor Prognosis (IF:4.452) |
Nair MG, Prabhu JS, Korlimarla A, Rajarajan S, Hari PS, Kaul R, Alexander A, Raghavan R, Srinath BS, Sridhar TS |
Cancer Med |
2020 |
9 |
Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity (IF:2.762) |
Crasta J, Ravikumar G, Rajarajan S, Gali S, Kulkarni KA, Vallikad E, Prabhu J |
Int J Gynecol Pathol |
2020 |
10 |
Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1 (Cite score- 1.63) |
Rajarajan S, Anupama CE, Jose B, Correa M, Sengupta S, Prabhu JS |
Mol Clin Oncol |
2020 |
11 |
miR-18a activates Wnt pathway in ER-positive breast cancer and is associated with poor prognosis (IF:4.452) |
Nair MG, Prabhu JS, Korlimarla A, Rajarajan S, P S H, Kaul R, Alexander A, Raghavan R, Srinath BS, Sridhar TS |
Cancer Med |
2020 |
12 |
Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer (IF:3.240) |
Bajaj R, Tripathi R, Sridhar TS, Korlimarla A, Choudhury KD, Suryavanshi M, Mehta A, Doval DC |
PLoS One |
2020 |
13 |
The impact of breast cancer on the patient and the family in Indian perspective |
Alexander A, Kaluve R, Prabhu JS, Korlimarla A, Srinath BS, Manjunath S, Patil S, Gopinath KS, Sridhar TS |
Indian J Palliat Care |
2019 |
14 |
Placental expression of angiogenesis-related genes and their receptors in IUGR pregnancies: correlation with fetoplacental and maternal parameters |
Ravikumar G, Mukhopadhyay A, Mani C, Kocchar P, Crasta J, Thomas T, Dwarkanath P, Thomas A, Kurpad AV, Sridhar TS |
J Matern Fetal Neonatal Med |
2019 |
15 |
Cystic Neutrophilic Granulomatous Mastitis: A Clinicopathological Study With 16s rRNA Sequencing for the Detection of Corynebacteria in Formalin-Fixed Paraffin-Embedded Tissue |
Naik MA, Korlimarla A, Shetty ST, Fernandes AM, Pai SA |
Int J Surg Pathol |
2019 |